MedPath

The Association Between Parathyroid Hormone and Preterm Labor

Completed
Conditions
Preterm Labor
Parathyroid Diseases
Interventions
Diagnostic Test: parathyroid hormone level
Diagnostic Test: serum electrolytes
Registration Number
NCT05688007
Lead Sponsor
Ain Shams Maternity Hospital
Brief Summary

This observational study aims to test the level of parathyroid hormone in pregnant women. The main question it aims to answer is:

n Pregnant women, are the levels of serum PTH, calcium, magnesium, phosphorus \& albumin similar in both preterm and term births?

Detailed Description

* Approval from ethical committee will be sought.

* Patients will be enrolled from Ain Shams University Maternity Hospital labor ward and antenatal outpatient clinic.

* History, examination and fetal ultrasound will be done to identify eligible patients.

History: a full detailed history including personal, menstrual, obstetric, present, past history and family history will be obtained.

Accurate last menstrual period date will be obtained, and gestational age will be calculated using Naegele's rule or first trimester ultrasound to identify preterm patients with gestational age (28-36 weeks).

Examination: general, abdominal and vaginal examination to identify patients in established labor with Regular uterine contractions are at least 3 in 10 min each lasting 40 seconds. Progressive cervical dilatation (at least 4 cm). Ultrasound: for (viability of fetus, fetal biometry and estimated fetal weight, amniotic fluid, placental localization).

Thus, two groups of patients will be identified:

1. Cases: established preterm labor - gestational age: (28-36 weeks)

2. Controls: pregnant women not in labor - gestational age: (28- 36 weeks)

* Venous blood samples will be withdrawn about (3ml) once from every patient within one hour from inclusion into the study to measure serum parathyroid hormone, calcium, magnesium, phosphorus and albumin levels.

* Samples will not be collected from an arm with an intravenous catheter if alternate sites are available.

* Patient collection site will be appropriately disinfected prior to sample collection.

* After collection, samples will be put in a red or yellow tube (serum separating tube) with a serum gel separator.

* Samples will be gently mixed immediately following collection into tube to ensure proper preservation of the analytes. 180° tube inversion, allowing bubble to travel the length of the tube, followed by return to upright position is one mix.

* Samples will be delivered to laboratory within 30 to 60 minutes.

* Data will be collected and recorded in a case report form (Age, parity, previous preterm births/ miscarriage, gestational age, measured levels of serum PTH, calcium, magnesium, phosphorus \& albumin , mode of delivery, birth weight).

* Statistical analysis will be done to get results.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
100
Inclusion Criteria
  • Pregnant women aged (18-40).
  • Gestational age (28-36 weeks).
Exclusion Criteria
  • Known maternal disease as diabetes, hypertension, renal disease, cardiac disease and liver disease.
  • Known hypo or hyperparathyroidism
  • Multiple pregnancy
  • Polyhydramnios
  • Premature rupture of membrane
  • Antepartum Hemorrhage
  • Uterine malformations e.g. bicornuate uterus
  • Smoking

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Casesserum electrolytespregnant women with established preterm labor - gestational age: (28-36 weeks), having: Regular uterine contractions are at least 3 in 10 min each lasting 40 seconds. Progressive cervical dilatation (at least 4 cm).
Controlsparathyroid hormone levelpregnant women not in labor - gestational age: (28- 36 weeks)
Controlsserum electrolytespregnant women not in labor - gestational age: (28- 36 weeks)
Casesparathyroid hormone levelpregnant women with established preterm labor - gestational age: (28-36 weeks), having: Regular uterine contractions are at least 3 in 10 min each lasting 40 seconds. Progressive cervical dilatation (at least 4 cm).
Primary Outcome Measures
NameTimeMethod
parathyroid hormone1 day

serum level of parathyroid hormone (ng/L)

Secondary Outcome Measures
NameTimeMethod
Calcium1 day

serum calcium level (mg/dl)

Magnesium1 day

serum magnesium level (meq/L)

Phosphorus1 day

serum phosphorus level (mg/dl)

Albumin1 day

serum albumin level (g/dl)

Trial Locations

Locations (1)

Ain Shams Maternity Hospital

🇪🇬

Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath